Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2012 Feb 1;185(3):286-90.
doi: 10.1164/rccm.201109-1644OC. Epub 2011 Nov 10.

Vitamin D levels and risk of acute exacerbations of chronic obstructive pulmonary disease: a prospective cohort study

Collaborators, Affiliations
Randomized Controlled Trial

Vitamin D levels and risk of acute exacerbations of chronic obstructive pulmonary disease: a prospective cohort study

Ken M Kunisaki et al. Am J Respir Crit Care Med. .

Abstract

Rationale: Low blood levels of 25-hydroxyvitamin D (25[OH]D) have been associated with a higher risk of respiratory infections in general populations and higher risk of exacerbations of lung disease in people with asthma. We hypothesized that low blood levels of 25(OH)D in patients with chronic obstructive pulmonary disease (COPD) would be associated with an increased risk of acute exacerbations of COPD (AECOPD).

Objectives: To determine if baseline 25(OH)D levels relate to subsequent AECOPD in a cohort of patients at high risk for AECOPD.

Methods: Plasma 25(OH)D was measured at baseline in 973 participants on entry to a 1-year study designed to determine if daily azithromycin decreased the incidence of AECOPD. Relationships between baseline 25(OH)D and AECOPD over 1 year were analyzed with time to first AECOPD as the primary outcome and exacerbation rate as the secondary outcome.

Measurements and main results: In this largely white (85%) sample of North American patients with severe COPD (mean FEV(1) 1.12L; 40% of predicted), mean 25(OH)D was 25.7 ± 12.8 ng/ml. A total of 33.1% of participants were vitamin D insufficient (≥20 ng/ml but <30 ng/ml); 32% were vitamin D deficient (<20 ng/ml); and 8.4% had severe vitamin D deficiency (<10 ng/ml). Baseline 25(OH)D levels had no relationship to time to first AECOPD or AECOPD rates.

Conclusions: In patients with severe COPD, baseline 25(OH)D levels are not predictive of subsequent AECOPD. Clinical trial registered with www.clinicaltrials.gov (NCT00119860).

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Distribution of vitamin D levels by season and ethnicity (upper panel ) and clinical center (lower panel). 25(OH)D = 25 hydroxyvitamin D; A. Arbor = Ann Arbor, MI; Balt = Baltimore, MD; Birm = Birmingham, AL; Bost = Boston, MA; Denv = Denver, CO; Minn = Minnesota; Phil = Philadelphia, PA; Pitt = Pittsburgh, PA; UCLA = University of California, Los Angeles; UCSF = University of California, San Francisco.

Comment in

References

    1. McGhan R, Radcliff T, Fish R, Sutherland ER, Welsh C, Make B. Predictors of rehospitalization and death after a severe exacerbation of COPD. Chest 2007;132:1748–1755 - PubMed
    1. Hoogendoorn M, Hoogenveen RT, Rutten-van Mölken MP, Vestbo J, Feenstra TL. Case fatality of COPD exacerbations: a meta-analysis and statistical modelling approach. Eur Respir J 2011;37:508–515 - PubMed
    1. Bourbeau J, Ford G, Zackon H, Pinsky N, Lee J, Ruberto G. Impact on patients’ health status following early identification of a COPD exacerbation. Eur Respir J 2007;30:907–913 - PubMed
    1. Strassels SA, Smith DH, Sullivan SD, Mahajan PS. The costs of treating COPD in the United States. Chest 2001;119:344–352 - PubMed
    1. Andersson F, Borg S, Jansson SA, Jonsson AC, Ericsson A, Prutz C, Ronmark E, Lundback B. The costs of exacerbations in chronic obstructive pulmonary disease (COPD). Respir Med 2002;96:700–708 - PubMed

Publication types

MeSH terms

Associated data